ChemicalBook--->CAS DataBase List--->1338542-14-5

1338542-14-5

1338542-14-5 Structure

1338542-14-5 Structure
IdentificationBack Directory
[Name]

OTS964
[CAS]

1338542-14-5
[Synonyms]

OTS964(free base)
Thieno[2,3-c]quinolin-4(5H)-one, 9-[4-[(1R)-2-(dimethylamino)-1-methylethyl]phenyl]-8-hydroxy-6-methyl-
[Molecular Formula]

C23H24N2O2S
[MDL Number]

MFCD29918155
[MOL File]

1338542-14-5.mol
[Molecular Weight]

392.51
Chemical PropertiesBack Directory
[Boiling point ]

501.7±50.0 °C(Predicted)
[density ]

1.232±0.06 g/cm3(Predicted)
[pka]

9.46±0.20(Predicted)
Hazard InformationBack Directory
[Uses]

OTS964 is an orally active, high affinity and selective TOPK inhibitor with an IC50 of 28 nM[1]. OTS964 is also a potent inhibitor of the cyclin-dependent kinase CDK11, which binds to CDK11B with a Kd of 40 nM[2].
[in vivo]

OTS964 (intravenously; 40 mg/kg on days 1, 4, 8, 11, 15, and 18) makes tumors shrinking even after the treatment and finally revealing complete regression[1].
OTS964 (oral administration; 50 or 100 mg/kg/day for 2 weeks) achieves complete tumor regression[1].

Animal Model:Nude mice bearing LU-99 lung cancer cells[1]
Dosage:40 mg/kg
Administration:Intravenously; on days 1, 4, 8, 11, 15, and 18
Result:The tumors continued shrinking even after the treatment and finally revealed complete regression.
Animal Model:Nude mice bearing LU-99 lung cancer cells[1]
Dosage:50 or 100 mg/kg
Administration: Oral administration; once every day for 2 weeks
Result:Achieved complete tumor regression.
[IC 50]

TOPK: 28 nM (IC50); CDK11B: 40 nM (Kd)
[References]

[1] Matsuo Y , et al. TOPK inhibitor induces complete tumor regression in xenograft models of human cancerthrough inhibition of cytokinesis. Sci Transl Med. 2014 Oct 22;6(259):259ra145. DOI:10.1126/scitranslmed.3010277
[2] Lin A, et al. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Sci Transl Med. 2019 Sep 11;11(509). DOI:10.1126/scitranslmed.aaw8412
[3] Lu H, et al. TOPK inhibits autophagy by phosphorylating ULK1 and promotes glioma resistance to TMZ. Cell Death Dis. 2019 Aug 5;10(8):583. DOI:10.1038/s41419-019-1805-9
1338542-14-5 suppliers list
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105 , +1-13798911105
Website: https://www.invivochem.com/
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Website: https://www.bocsci.com
Company Name: Jinan Jiuli Biotechnology Co. , Ltd.  
Tel: 15865264761
Website: www.hezefdc.com/ShowSupplierProductsList89365/0_EN.htm
Company Name: InvivoChem  
Tel: 13549236410
Website: https://www.invivochem.cn/
Company Name: Shanghai Yifei Biotechnology Co. , Ltd.  
Tel: 021-65675885 18964387627
Website: http://www.efebio.com
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Company Name: Shanghai Fengyong Biotechnology Co., Ltd.  
Tel: 021-10000000 13000000000
Website: www.abmole.cn
Company Name: Absin Bioscience Inc.  
Tel: 021-38015121-8802
Website: http://www.absin.cn
Company Name: Shanghai Hao Zhun Biological Technology Co., Ltd.  
Tel: 15800340161
Website: www.zzsrm.com
Company Name: Cayman Chemical Company  
Tel: (800) 364-9897
Website: www.caymanchem.com
Tags:1338542-14-5 Related Product Information